John P. Sfakianos
Papers
1
Total Citations
2
H-Index
1
About
John P. Sfakianos is a urologic oncologist whose research is centered on the diagnosis, surgical management, and post-treatment surveillance of bladder cancer. His work reflects a growing commitment to precision medicine approaches that tailor clinical care to individual patient biology. In his notably forward-thinking 2025 diagnostic accuracy study, Sfakianos and colleagues investigated the potential of circulating tumor DNA (ctDNA) as a biomarker for stratifying bladder cancer patients following radical cystectomy. The study proposed that patients with undetectable ctDNA levels post-surgery may safely undergo less intensive imaging surveillance protocols — a finding with meaningful implications for reducing patient burden, minimizing radiation exposure, and optimizing healthcare resources without compromising oncologic outcomes. Though early in its citation trajectory with 2 citations, the work represents an emerging and clinically significant contribution to liquid biopsy applications in urologic cancers. Sfakianos's research sits at the intersection of surgical oncology and molecular diagnostics, positioning him as a contributor to the evolving conversation around smarter, biomarker-driven follow-up strategies for one of the most challenging urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1